Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein].

Ahmadzadehfar H, Albers P, Bockisch A, Boegemann M, Böhme C, Burchert W, Dietlein M, Drzezga A, Fabry U, Feldmann G, Heidenreich A, Heinzel A, Herrmann K, Heyll A, Höhling C, Kreuzer C, Laufer D, Mengel R, Mottaghy FM, Müller HW, Müller SC, Ost E, Rahbar K, Reifenhäuser W, Schäfers M, Schlenkhoff C, Schmidt M, Schmidt-Wolf I, Wildenhain C, Zimmer B, Essler M.

Urologe A. 2018 Jun;57(6):709-713. doi: 10.1007/s00120-018-0642-2. Review. German.

PMID:
29671080
2.

Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy.

Ahmadzadehfar H, Schlolaut S, Fimmers R, Yordanova A, Hirzebruch S, Schlenkhoff C, Gaertner FC, Awang ZH, Hauser S, Essler M.

Oncotarget. 2017 Oct 7;8(61):103108-103116. doi: 10.18632/oncotarget.21600. eCollection 2017 Nov 28.

3.

Combination of 177Lu-PSMA-617 and External Radiotherapy for the Treatment of Cerebral Metastases in Patients With Castration-Resistant Metastatic Prostate Cancer.

Wei X, Schlenkhoff C, Schwarz B, Essler M, Ahmadzadehfar H.

Clin Nucl Med. 2017 Sep;42(9):704-706. doi: 10.1097/RLU.0000000000001763.

PMID:
28719450
4.

Possible Treatment Approach to an Extravasation of 177Lu-PSMA-617.

Schlenkhoff CD, Essler M, Ahmadzadehfar H.

Clin Nucl Med. 2017 Aug;42(8):639-640. doi: 10.1097/RLU.0000000000001715.

PMID:
28574879
5.

Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617.

Ahmadzadehfar H, Wegen S, Yordanova A, Fimmers R, Kürpig S, Eppard E, Wei X, Schlenkhoff C, Hauser S, Essler M.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1448-1454. doi: 10.1007/s00259-017-3716-2. Epub 2017 May 9.

PMID:
28488028
6.

[18F]Fluorodeoxyglucose Positron Emission Tomography Reveals a Complete Remission of Refractory Metastatic Melanoma after Therapy with Ipilimumab.

Yordanova A, Schlenkhoff C, Palmedo H, Essler M, Ahmadzadehfar H.

Indian J Nucl Med. 2017 Jan-Mar;32(1):66-67. doi: 10.4103/0972-3919.198490.

7.

Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617.

Wei X, Schlenkhoff C, Sopora C, Essler M, Ahmadzadehfar H.

Clin Nucl Med. 2016 Nov;41(11):894-895.

PMID:
27607162
8.

68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer.

Ahmadzadehfar H, Schlenkhoff CD, Rogenhofer S, Yordanova A, Essler M.

Clin Nucl Med. 2016 Sep;41(9):695-6. doi: 10.1097/RLU.0000000000001286.

PMID:
27405025
9.

Metastatic Prostate Cancer With Restored Hormone-Response After Radioligand Therapy With 177Lu-PSMA-617.

Schlenkhoff CD, Knüpfer E, Essler M, Ahmadzadehfar H.

Clin Nucl Med. 2016 Jul;41(7):572-3. doi: 10.1097/RLU.0000000000001200.

PMID:
26909718
10.

Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer.

Schlenkhoff CD, Gaertner F, Essler M, Schmidt M, Ahmadzadehfar H.

Clin Nucl Med. 2016 Jun;41(6):478-80. doi: 10.1097/RLU.0000000000001195.

PMID:
26909716
11.

Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer.

Ahmadzadehfar H, Eppard E, Kürpig S, Fimmers R, Yordanova A, Schlenkhoff CD, Gärtner F, Rogenhofer S, Essler M.

Oncotarget. 2016 Mar 15;7(11):12477-88. doi: 10.18632/oncotarget.7245.

12.

68Ga-Labeled Anti-Prostate-Specific Membrane Antigen Peptide as Marker for Androgen Deprivation Therapy Response in Prostate Cancer.

Schlenkhoff CD, Gaertner F, Essler M, Hauser S, Ahmadzadehfar H.

Clin Nucl Med. 2016 May;41(5):423-5. doi: 10.1097/RLU.0000000000001158.

PMID:
26859213
13.

Two flow-related aneurysms of the circle of Willis in an elderly patient with bilateral subclavian steal syndrome presenting as two different clinical manifestations.

Schaarschmidt BM, Schlenkhoff CD, Heuser LJ.

Rofo. 2013 May;185(5):482-4. doi: 10.1055/s-0032-1330415. Epub 2013 Apr 24. No abstract available.

14.

[Pulmonary edema in pulmonary leukostasis in acute myeloid leukemia].

Schlenkhoff CD, Heuser LJ.

Rofo. 2012 Sep;184(9):832-4. doi: 10.1055/s-0032-1312785. Epub 2012 Jun 1. German. No abstract available.

PMID:
22661389
15.

[Serum levels of lidocaine as affected by high frequency jet ventilation during bronchoscopies under local anesthesia].

Scieszka S, Droste H, Mayer M, Schlenkhoff D.

Anaesthesist. 1988 Jul;37(7):420-4. German.

PMID:
3414954
16.

[Extraperitoneal perforation of the rectum following roentgen contrast enema].

Schlenkhoff D, Koutsis J, Strosche H.

Zentralbl Chir. 1987;112(15):981-3. German. No abstract available.

PMID:
3673307
17.

[Magnetic resonance tomography in injuries of the cervical spine].

Meydam K, Sehlen S, Schlenkhoff D, Kiricuta JC, Beyer HK.

Rofo. 1986 Dec;145(6):657-60. German.

PMID:
3025951
18.

Penetration of ciprofloxacin into human lung tissue following intravenous injection.

Schlenkhoff D, Dalhoff A, Knopf J, Opferkuch W.

Infection. 1986 Nov-Dec;14(6):299-300. No abstract available.

PMID:
3818107
19.

[Dupuytren's contracture--late results of surgical treatment at a general surgery clinic].

Mayer M, Donner U, Schlenkhoff D.

Chirurg. 1986 Nov;57(11):733-6. German.

PMID:
3803028
20.

The use of high-frequency jet-ventilation in operative bronchoscopy.

Schlenkhoff D, Droste H, Scieszka S, Vogt H.

Endoscopy. 1986 Sep;18(5):192-4.

PMID:
3780586

Supplemental Content

Loading ...
Support Center